Deutsche Bank Ag\ Recursion Pharmaceuticals, Inc. Transaction History

Deutsche Bank Ag\

$240 Billion
Q3 2024

A detailed history of Deutsche Bank Ag\ transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 141,729 shares of RXRX stock, worth $881,554. This represents 0.0% of its overall portfolio holdings.

Number of Shares

141,729

Previous 109,877 28.99%

Holding current value

$881,554

Previous $824,000 13.23%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$5.92 - $8.6 $188,563 - $273,927	31,852 Added 28.99%	141,729 $933,000
Q2 2024 Aug 14, 2024	BUY	$7.35 - $10.05 $211,643 - $289,389	28,795 Added 35.51%	109,877 $824,000
Q1 2024 May 15, 2024	BUY	$9.13 - $15.52 $24,970 - $42,447	2,735 Added 3.49%	81,082 $808,000
Q4 2023 Feb 14, 2024	BUY	$5.09 - $10.79 $94,974 - $201,330	18,659 Added 31.26%	78,347 $772,000
Q3 2023 Nov 09, 2023	BUY	$6.59 - $15.86 $52,542 - $126,451	7,973 Added 15.42%	59,688 $456,000
Q2 2023 Aug 14, 2023	SELL	$4.56 - $9.94 $168,469 - $367,233	-36,945 Reduced 41.67%	51,715 $386,000
Q1 2023 May 15, 2023	BUY	$6.42 - $9.64 $113,550 - $170,502	17,687 Added 24.92%	88,660 $591,000
Q4 2022 Feb 13, 2023	BUY	$7.16 - $12.7 $92,385 - $163,868	12,903 Added 22.22%	70,973 $547,000
Q3 2022 Nov 14, 2022	SELL	$7.83 - $13.6 $48,921 - $84,972	-6,248 Reduced 9.71%	58,070 $618,000
Q2 2022 Aug 11, 2022	SELL	$5.04 - $9.26 $7,464 - $13,714	-1,481 Reduced 2.25%	64,318 $523,000
Q1 2022 May 13, 2022	SELL	$6.16 - $18.03 $43,132 - $126,246	-7,002 Reduced 9.62%	65,799 $471,000
Q4 2021 Feb 11, 2022	BUY	$16.14 - $21.86 $904,469 - $1.23 Million	56,039 Added 334.32%	72,801 $1.25 Million
Q3 2021 Nov 04, 2021	BUY	$19.03 - $41.33 $69,269 - $150,441	3,640 Added 27.74%	16,762 $385,000
Q2 2021 Aug 11, 2021	BUY	$18.0 - $37.42 $236,196 - $491,025	13,122 New	13,122 $479,000

Others Institutions Holding RXRX

# of Institutions

287

Shares Held

242M

Call Options Held

1.35M

Put Options Held

2.32M

View Full List

About RECURSION PHARMACEUTICALS, INC.

Ticker RXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 180,480,000
Market Cap $1.12B
Description
Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...

More about RXRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account